87 venture-backed companies IPO'd in 2019, in line with 2018. These companies raised $26.3 billion in the IPO market, a more than $11 billion increase over the previous year. Driven by strong biotech activity and a rising number of large tech unicorns,...read more
NextCure, a clinical-stage biotech developing next-gen cancer immunotherapies, raised $75 million by offering 5 million shares at $15, the midpoint of the range of $14 to $16. NextCure plans to list on the Nasdaq under the symbol NXTC. Morgan Stanley,...read more
If 2019 is indeed the "year of Uber," then the week ahead can only be the "week of Uber." After years of IPO speculation, Uber (UBER) is expected to raise $8.5 billion at the $47 midpoint, with insiders selling $1.3 billion in the...read more
The 2019 IPO market's most active venture capital firms
87 venture-backed companies IPO'd in 2019, in line with 2018. These companies raised $26.3 billion in the IPO market, a more than $11 billion increase over the previous year. Driven by strong biotech activity and a rising number of large tech unicorns,...read more
US IPO Weekly Recap: Small Chinese and healthcare deals price down in an 8-IPO week
Eight small companies and four SPACs entered the public market this past week. Continuing a 4Q trend, all eight deals...read more
Cancer biotech NextCure prices IPO at $15 midpoint
NextCure, a clinical-stage biotech developing next-gen cancer immunotherapies, raised $75 million by offering 5 million shares at $15, the midpoint of the range of $14 to $16. NextCure plans to list on the Nasdaq under the symbol NXTC. Morgan Stanley,...read more
US IPO Week Ahead: It's Uber uber alles with biggest IPO in 5 years
If 2019 is indeed the "year of Uber," then the week ahead can only be the "week of Uber." After years of IPO speculation, Uber (UBER) is expected to raise $8.5 billion at the $47 midpoint, with insiders selling $1.3 billion in the...read more